HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of a novel frameshift mutation (383insT) in the RUNX2 (PEBP2 alpha/CBFA1/AML3) gene in a Japanese patient with cleidocranial dysplasia.

Abstract
Cleidocranial dysplasia (CCD) is an autosomal dominant disorder due to mutations in runt-related gene 2 (RUNX2)/polyomavirus enhancer-binding protein 2alphaA (PEBP2alphaA)/core-binding factor A1 (CBFA1)/acute myeloid leukemia 3 (AML3). To investigate the RUNX2 mutations in a Japanese patient with classic CCD, we analyzed the RUNX2 gene using polymerase chain reaction (PCR)-single-strand conformation polymorphism and PCR-restriction fragment length polymorphism. The patient had hypoplasia of the clavicles, patent fontanelles, short stature, supernumerary teeth, and retention of deciduous dentition. We identified a 1-bp insertion (383insT) at codon 128 of the RUNX2 gene. The 383T insertion affects the conserved residue in the runt domain and results in premature termination in the runt domain.
AuthorsM Goseki-Sone, H Orimo, A Watanabe, R Hamatani, M Yokozeki, K Ohyama, T Kuroda, H Watanabe, H Miyazaki, T Shimada, S Oida
JournalJournal of bone and mineral metabolism (J Bone Miner Metab) Vol. 19 Issue 4 Pg. 263-6 ( 2001) ISSN: 0914-8779 [Print] Japan
PMID11448020 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Core Binding Factor Alpha 1 Subunit
  • Neoplasm Proteins
  • Transcription Factors
  • DNA
Topics
  • Adolescent
  • Amino Acid Sequence
  • Base Sequence
  • Clavicle (diagnostic imaging)
  • Cleidocranial Dysplasia (diagnostic imaging, genetics)
  • Core Binding Factor Alpha 1 Subunit
  • DNA (genetics)
  • Frameshift Mutation
  • Humans
  • Japan
  • Male
  • Neoplasm Proteins
  • Phenotype
  • Polymorphism, Restriction Fragment Length
  • Polymorphism, Single-Stranded Conformational
  • Radiography
  • Tooth (diagnostic imaging)
  • Transcription Factors (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: